Literature DB >> 7074609

Role of laminin in the attachment and metastasis of murine tumor cells.

V P Terranova, L A Liotta, R G Russo, G R Martin.   

Abstract

We have studied the attachment of two murine metastatic cell lines and of a transformed, nonmetastatic sarcoma cell line to type IV (basement membrane) collagen. The metastatic cells attached preferentially to type IV collagen, whereas the nonmetastic cells attached best to type I collagen. Laminin increased both the rate and the number of metastatic cells attaching to type IV collagen, while fibronectin had no effect. Antibodies to laminin prevented the attachment of metastatic cells to type IV collagen, while antibodies to fibronectin prevented the attachment of the nonmetastatic cells. The number of pulmonary metastases which formed after i.v. injection of cells into C57BL mice was used to measure the metastatic propensity of these cell lines. A subpopulation of the metastatic cells selected for by their ability to attach to type IV collagen in the presence of laminin produced more metastases than did unattached cells or cells attached with fibronectin. In addition, incubation of metastatic cells with antibody to laminin prior to injection into mice markedly reduced the number of lung metastases. These data suggest that laminin promotes the attachment of metastatic tumor cells to basement membrane during the metastaatic process.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7074609

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  84 in total

1.  Laminin-induced retinoblastoma cell differentiation: possible involvement of a 100-kDa cell-surface laminin-binding protein.

Authors:  A Albini; D M Noonan; A Melchiori; G F Fassina; M Percario; S Gentleman; J Toffenetti; G J Chader
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

Review 2.  Use of basement membrane markers in tumour diagnosis.

Authors:  A J d'Ardenne
Journal:  J Clin Pathol       Date:  1989-05       Impact factor: 3.411

3.  Transglutaminase stabilizes melanoma adhesion under laminar flow.

Authors:  D G Menter; J T Patton; T V Updyke; R S Kerbel; M Maamer; L V McIntire; G L Nicolson
Journal:  Cell Biophys       Date:  1991-04

Review 4.  The role of cell adhesion proteins--laminin and fibronectin--in the movement of malignant and metastatic cells.

Authors:  J B McCarthy; M L Basara; S L Palm; D F Sas; L T Furcht
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

5.  The in vitro invasiveness and interactions with laminin of K-1735 melanoma cells. Evidence for different laminin-binding affinities in high and low metastatic variants.

Authors:  A Albini; S L Aukerman; R C Ogle; D M Noonan; R Fridman; G R Martin; I J Fidler
Journal:  Clin Exp Metastasis       Date:  1989 Jul-Aug       Impact factor: 5.150

6.  Attachment, spreading and growth in vitro of highly malignant and low malignant murine fibrosarcoma cells.

Authors:  J Varani; I A Grimstad; R N Knibbs; T Hovig; J P McCoy
Journal:  Clin Exp Metastasis       Date:  1985 Jan-Mar       Impact factor: 5.150

7.  Basement membrane proteins in synovial membrane: distribution in rheumatoid arthritis and synthesis by fibroblast-like cells.

Authors:  M Schneider; B Voss; J Rauterberg; M Menke; T Pauly; R K Miehlke; J Friemann; U Gerlach
Journal:  Clin Rheumatol       Date:  1994-03       Impact factor: 2.980

8.  Influence of collagen substrata on glycosaminoglycan production by B16 melanoma cells.

Authors:  S D Luikart; C A Maniglia; A C Sartorelli
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

9.  Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues.

Authors:  M R Buck; D G Karustis; N A Day; K V Honn; B F Sloane
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

Review 10.  Shaping future strategies for the pharmacological control of tumor cell metastases.

Authors:  R G Greig; D L Trainer
Journal:  Cancer Metastasis Rev       Date:  1986       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.